These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37490989)

  • 61. Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer.
    Hou Z; Song F; Xing J; Zheng Z; Liu S; Liu Z
    J Ethnopharmacol; 2022 Jun; 292():115222. PubMed ID: 35341933
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.
    Li Y; Ji X; Wu H; Li X; Zhang H; Tang D
    J Ethnopharmacol; 2021 Oct; 278():114207. PubMed ID: 34000365
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function.
    Hu J; Huang H; Che Y; Ding C; Zhang L; Wang Y; Hao H; Shen H; Cao L
    J Ethnopharmacol; 2021 Feb; 266():113394. PubMed ID: 32941971
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies.
    Liu C; Yu H; Li X; Gong Y; Wu P; Feng QS
    J Ethnopharmacol; 2022 Mar; 285():114913. PubMed ID: 34910953
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.
    Ma C; Han M; Heinrich B; Fu Q; Zhang Q; Sandhu M; Agdashian D; Terabe M; Berzofsky JA; Fako V; Ritz T; Longerich T; Theriot CM; McCulloch JA; Roy S; Yuan W; Thovarai V; Sen SK; Ruchirawat M; Korangy F; Wang XW; Trinchieri G; Greten TF
    Science; 2018 May; 360(6391):. PubMed ID: 29798856
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rheum officinale Baill. Treats zebrafish embryo thrombosis by regulating NOS3 expression in the arginine biosynthesis pathway.
    Zhang YR; Liu YR; Tang ZS; Song ZX; Zhang JW; Chang BJ; Zhao ML; Xu J
    Phytomedicine; 2022 May; 99():153967. PubMed ID: 35182903
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies.
    Petrick JL; Florio AA; Koshiol J; Pfeiffer RM; Yang B; Yu K; Chen CJ; Yang HI; Lee MH; McGlynn KA
    Int J Cancer; 2020 Nov; 147(10):2743-2753. PubMed ID: 32406072
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A UPLC-QTOF/MS-based hepatic tissue metabolomics approach deciphers the mechanism of Huachansu tablets-based intervention against hepatocellular carcinoma.
    Chen C; Wu H; Fu X; Li R; Cheng H; Wang M; Zhou A; Zhang M; Li Q
    J Pharm Biomed Anal; 2024 Feb; 239():115875. PubMed ID: 38061172
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome.
    Golonka RM; Vijay-Kumar M
    Adv Cancer Res; 2021; 149():171-255. PubMed ID: 33579424
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    Li X; Xiao Y; Huang Y; Song L; Li M; Ren Z
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500975
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modification effects of SanWei GanJiang Powder on liver and intestinal damage through reversing bile acid homeostasis.
    Li N; Wang B; Wu Y; Luo X; Chen Z; Sang C; Xiong T
    Biomed Pharmacother; 2019 Aug; 116():109044. PubMed ID: 31174088
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antitumor effects and chemical compositions of Eupolyphaga sinensis Walker ethanol extract.
    Ge GF; Yu CH; Yu B; Shen ZH; Zhang DL; Wu QF
    J Ethnopharmacol; 2012 May; 141(1):178-82. PubMed ID: 22366674
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Dual Coverage Monitoring of the Bile Acids Profile in the Liver-Gut Axis throughout the Whole Inflammation-Cancer Transformation Progressive: Reveal Hepatocellular Carcinoma Pathogenesis.
    Xing L; Zhang Y; Li S; Tong M; Bi K; Zhang Q; Li Q
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Qi-Zhi-Wei-Tong granules alleviates chronic non-atrophic gastritis in mice by altering the gut microbiota and bile acid metabolism.
    Chen M; Li Y; Li L; Ma Q; Zhou X; Ding F; Mo X; Zhu W; Bian Q; Zou X; Xue F; Yan L; Li X; Chen J
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117304. PubMed ID: 37838294
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Integrated network pharmacology and gut microbiome analysis to reveal the mechanism of Qu-Zhuo-Tong-Bi decoction against hyperuricemia and gout.
    Song S; Fan M; Wen X; Shi X; Lou Y; He Z; Wen C; Shao T
    J Ethnopharmacol; 2023 Nov; 316():116736. PubMed ID: 37286117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health.
    Jia B; Park D; Hahn Y; Jeon CO
    Gut Microbes; 2020 Sep; 11(5):1300-1313. PubMed ID: 32329665
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Total glycosides contribute to the anti-diarrheal effects of Qiwei Baizhu Powder
    Xie G; Deng N; Zheng T; Peng X; Zhang S; Tan Z
    Front Cell Infect Microbiol; 2022; 12():945263. PubMed ID: 36072221
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Active ingredients screening and pharmacological mechanism research of curcumae rhizoma-sparganii rhizoma herb pair ameliorates liver fibrosis based on network pharmacology.
    Hao M; Yao Z; Zhao M; Chen Z; Wang P; Sang X; Yang Q; Wang K; Han X; Cao G
    J Ethnopharmacol; 2023 Apr; 305():116111. PubMed ID: 36592822
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The gut microbiome-bile acid axis in hepatocarcinogenesis.
    Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
    Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.